Regenerative medicine begins before any treatment is given.
A living body is already regulating, communicating, clearing, rebuilding and responding every second of the day.
Regenerative medicine asks whether there are intelligent ways to participate in those biological processes when there is a meaningful clinical reason to do so.
At SCIENTIA Institute in Cabo, we begin with that question, not with a product.
What does regeneration actually mean?
Your tissues are not static.
Cells communicate through proteins, lipids, nucleic acids and other signals. Immune cells respond to damage and change. Extracellular matrix is continually remodeled. Bone responds to load. Proteins are made and removed. Injured tissue initiates complex biological responses without being instructed to do so by a physician.
Medicine did not invent regeneration.
We entered a conversation that biology was already having.
This is why the useful question is not simply, “Can we give something regenerative?”
It is:
What process are we trying to influence, and why does that matter for this particular person?
What counts as regenerative medicine?
The field is broad.
Lifestyle, nutrition, metabolic health, hormones, mechanical loading and biophysical signals can all affect biological environments involved in adaptation and maintenance.
At another level, regenerative medicine may involve cells, extracellular vesicles, immune-cell therapies or other biologic approaches.
These are not interchangeable.
A mesenchymal stromal cell is not a MUSE cell.
An extracellular vesicle is not a cell.
An NK cell belongs to a different branch of biology entirely.
A gene-based therapy is another category again.
The name of the therapy tells us very little until we understand the biology inside it.
How does SCIENTIA approach stem cells and MUSE cells?
We begin with provenance.
Where did the material come from?
What cell population is present?
How was it processed?
How was it handled?
What documentation belongs to the specific batch?
What evidence relates to the proposed use?
MUSE cells are of particular scientific interest because they represent a distinct stress-enduring cell population with biological characteristics that differ from conventional mesenchymal stromal cells.
That makes them worth understanding.
It does not make them automatically appropriate for everyone.
The more advanced the material, the more precise the questions should become.
What about exosomes and extracellular vesicles?
Cells communicate partly by releasing extracellular vesicles that can carry molecular information between cells.
That biology is fascinating.
It also means the word “exosome” alone is not enough.
Source matters. Characterization matters. Processing matters. Storage matters. Route matters. The intended clinical question matters.
At SCIENTIA, extracellular vesicle and exosome-based approaches are treated as a distinct category of biologic medicine, with their evidence and provenance considered separately from cell therapies.
What about NK cell therapy?
Natural killer cells are part of innate immune surveillance.
They are biologically and clinically different from stem-cell therapies and are being studied extensively within modern immunology and cell therapy.
When NK-cell approaches are considered, the conversation begins with indication, immune context, product characteristics, evidence and follow-up.
Not with the fact that the technology exists.
What about gene therapy?
Gene-based medicine operates at another level.
Platforms such as AAV vectors and non-viral DNA systems including minicircle technology deliver biological instructions in different ways.
They differ in mechanism, duration, delivery, immune considerations and potential repeatability.
We do not treat “gene therapy” as one therapy.
The meaningful questions are much more specific:
Which gene?
Which tissue?
Which delivery system?
Why?
For how long should expression occur?
What evidence exists?
How would the result be followed?
When does advanced regenerative medicine belong?
Sometimes it does not belong first.
A person may have nutritional deficiencies, metabolic dysfunction, poor sleep, inadequate protein, hormonal issues or another correctable problem that deserves attention before an advanced biologic is considered.
Sometimes the clinical question does support moving further.
And sometimes there is not enough reason to intervene.
The existence of a sophisticated therapy is not itself an indication to use it.
What does “under protocol” mean?
When frontier work is considered for a defined clinical question, SCIENTIA uses protocol thinking.
The question is stated.
Relevant endpoints are identified before the intervention.
Measurements are taken at appropriate times.
The result is recorded.
The evidence is not assumed from the fact that a treatment was given.
This does not turn an individual patient into a clinical trial.
It keeps the question honest.
Regenerative medicine in Cabo
SCIENTIA Institute is based at the Koral Center in Cabo, Baja California Sur, working in collaboration with Hospital H+ Los Cabos.
Advanced regenerative therapies are discussed in physician consultation, where the person, indication, evidence, provenance, risks and alternatives can be considered together.
Frequently asked questions
What is regenerative medicine?
Regenerative medicine is a broad field concerned with biological repair, signaling, tissue maintenance and restoration of function. It may include established medical care as well as cells, extracellular vesicles, immune-cell therapies and other emerging biologic approaches.
Are all stem-cell products the same?
No. Tissue source, cell population, processing, expansion, storage, handling, viability and characterization can differ substantially. A cell count alone is not a complete description of a cell product.
What are MUSE cells?
MUSE cells, or multilineage-differentiating stress-enduring cells, are a distinct stress-resistant cell population identified within mesenchymal tissues. Their biology differs from conventional mesenchymal stromal cell populations, which is why they are studied separately.
Does SCIENTIA offer exosomes?
Extracellular vesicle and exosome-based biologic approaches may be discussed within SCIENTIA's regenerative program. The specific product, provenance, evidence, intended use and regulatory context must be evaluated in consultation.
How do I know whether regenerative medicine is appropriate for me?
That is a clinical decision rather than a website answer. SCIENTIA begins with assessment, history and the specific problem being considered. Sometimes an advanced biologic is relevant. Sometimes another intervention should come first.
SCIENTIA Regenerative Medicine · Cabo, Baja California Sur
The biology comes before longevity.